Related Experiment Videos
High-throughput, big data and complexity in clinical proteomics: an interview with Jasminka Godovac-Zimmermann
Jasminka Godovac-Zimmermann1, Claire Raison
1a Proteomics & Molecular Cell Dynamics, University College London, Royal Free Campus, Rowland Hill Street, London, NW3 2PF, UK.
Expert Review of Molecular Diagnostics
|September 15, 2015
Summary
Professor Jasminka Godovac-Zimmermann discusses her work in proteomics for cancer research and systems biology. She explores the clinical impact of proteomics and its future integration with diagnostics.
Area of Science:
- Proteomics and Molecular Cell Dynamics
- Cancer Research
- Systems Biology
Background:
- Professor Jasminka Godovac-Zimmermann, PhD, leads the Proteomics and Molecular Cell Dynamics Group at University College London.
- Specializing in protein chemistry, her training includes work at the Max Planck Institute of Biochemistry.
Discussion:
- The interview covers the clinical applications and implications of current proteomics research.
- It delves into the intersection of proteomics and molecular cell dynamics in understanding disease.
Key Insights:
- Focus on proteomics in cancer research provides insights into disease mechanisms.
- Systems biology approaches are crucial for understanding complex cellular processes.
Outlook:
- Professor Godovac-Zimmermann shares her predictions for the future of proteomics in diagnostics.
- The potential for integrating proteomics with clinical diagnostics is a key area of future development.